Want to see XBIO full AI Analyst Report?
Xenetic Biosciences (XBIO) Income Statement
Xenetic Biosciences Income Statement
Last quarter (Q2 2026), Xenetic Biosciences's total revenue was $660.60K, an increase of 11.99% from the same quarter last year. In Q2, Xenetic Biosciences's net income was $-929.70K. See Xenetic Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 2.98M | $ 2.50M | $ 2.54M | $ 1.71M | $ 1.16M | |
| $ 2.98M | $ 2.50M | $ 2.54M | $ 1.71M | $ 1.16M | |
| $ 5.81M | $ 6.70M | $ 7.06M | $ 8.42M | $ 6.91M | |
| Depreciation and Amortization | $ 0.00 | $ 153.34K | $ 0.00 | $ 27.04K | $ 35.48K |
| $ -2.68M | $ -3.81M | $ -4.13M | $ -6.53M | $ -5.61M | |
| $ -2.83M | $ -4.20M | $ -4.52M | $ -6.72M | $ -5.75M | |
| $ 153.72K | $ 244.15K | $ 381.14K | $ 165.56K | $ 101.59K | |
| $ -2.68M | $ -3.96M | $ -4.13M | $ -6.55M | $ -5.65M | |
| $ -2.68M | $ -3.96M | $ -4.13M | $ -6.55M | $ -5.65M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.58 | $ -2.57 | $ -2.71 | $ -4.49 | $ -5.39 |
| Diluted EPS | $ -1.58 | $ -2.57 | $ -2.71 | $ -4.49 | $ -5.39 |
| Weighted Average Shares Outstanding | 1.70M | 1.54M | 1.53M | 1.42M | 1.03M |
| Weighted Average Shares Outstanding (Diluted) | 1.70M | 1.54M | 1.53M | 1.42M | 1.03M |
Currency in USD